OWENS & MINOR INC (OMI) Stock Fundamental Analysis
NYSE:OMI - New York Stock Exchange, Inc. - US6907321029 - Common Stock
Overall OMI gets a fundamental rating of 4 out of 10. We evaluated OMI against 108 industry peers in the Health Care Providers & Services industry. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. OMI is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year OMI was profitable.
OMI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
Each year in the past 5 years OMI had a positive operating cash flow.
1.2 Ratios
OMI has a Return On Assets (-0.96%) which is in line with its industry peers.
With a Return On Equity value of -5.58%, OMI perfoms like the industry average, outperforming 49.53% of the companies in the same industry.
The Return On Invested Capital of OMI (6.98%) is better than 71.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OMI is in line with the industry average of 8.27%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -5.58% | ||
| ROIC | 6.98% |
ROA(3y)1.96%
ROA(5y)1.01%
ROE(3y)7.17%
ROE(5y)2.44%
ROIC(3y)8.85%
ROIC(5y)7.96%
1.3 Margins
OMI has a Operating Margin of 2.61%. This is comparable to the rest of the industry: OMI outperforms 52.34% of its industry peers.
OMI's Operating Margin has improved in the last couple of years.
The Gross Margin of OMI (20.72%) is worse than 61.68% of its industry peers.
In the last couple of years the Gross Margin of OMI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 20.72% |
OM growth 3Y3.01%
OM growth 5Y19.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.84%
GM growth 5Y12.59%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), OMI is creating some value.
Compared to 1 year ago, OMI has more shares outstanding
The number of shares outstanding for OMI has been increased compared to 5 years ago.
OMI has a better debt/assets ratio than last year.
2.2 Solvency
OMI has an Altman-Z score of 2.57. This is not the best score and indicates that OMI is in the grey zone with still only limited risk for bankruptcy at the moment.
OMI has a Altman-Z score (2.57) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.11 is on the high side and indicates that OMI has dependencies on debt financing.
OMI has a Debt to Equity ratio of 2.11. This is in the lower half of the industry: OMI underperforms 78.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.57 |
ROIC/WACC0.89
WACC7.88%
2.3 Liquidity
A Current Ratio of 1.09 indicates that OMI should not have too much problems paying its short term obligations.
OMI has a worse Current ratio (1.09) than 73.83% of its industry peers.
A Quick Ratio of 0.45 indicates that OMI may have some problems paying its short term obligations.
OMI has a Quick ratio of 0.45. This is amonst the worse of the industry: OMI underperforms 91.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.45 |
3. Growth
3.1 Past
OMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.74%, which is quite impressive.
The Earnings Per Share has been growing slightly by 3.23% on average over the past years.
Looking at the last year, OMI shows a small growth in Revenue. The Revenue has grown by 4.22% in the last year.
The Revenue has been growing slightly by 1.87% on average over the past years.
EPS 1Y (TTM)74.74%
EPS 3Y-14.68%
EPS 5Y3.23%
EPS Q2Q%-4.55%
Revenue 1Y (TTM)4.22%
Revenue growth 3Y6.81%
Revenue growth 5Y1.87%
Sales Q2Q%4.95%
3.2 Future
The Earnings Per Share is expected to grow by 15.44% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y11.89%
EPS Next 2Y17.45%
EPS Next 3Y18.74%
EPS Next 5Y15.44%
Revenue Next Year3.75%
Revenue Next 2Y3.75%
Revenue Next 3Y3.73%
Revenue Next 5Y5.38%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.99 indicates a reasonable valuation of OMI.
OMI's Price/Earnings ratio is rather cheap when compared to the industry. OMI is cheaper than 95.33% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, OMI is valued rather cheaply.
OMI is valuated cheaply with a Price/Forward Earnings ratio of 7.95.
Based on the Price/Forward Earnings ratio, OMI is valued cheaply inside the industry as 95.33% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of OMI to the average of the S&P500 Index (24.44), we can say OMI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.99 | ||
| Fwd PE | 7.95 |
4.2 Price Multiples
OMI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OMI is cheaper than 93.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.4 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OMI's earnings are expected to grow with 18.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)2.78
EPS Next 2Y17.45%
EPS Next 3Y18.74%
5. Dividend
5.1 Amount
No dividends for OMI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OWENS & MINOR INC
NYSE:OMI (1/21/2025, 8:18:36 PM)
After market: 14.92 0 (0%)14.92
+0.34 (+2.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.91%
Inst Owner Change-0.01%
Ins Owners2.2%
Ins Owner Change-0.93%
Market Cap1.15B
Analysts49.23
Price Target16.66 (11.66%)
Short Float %5.58%
Short Ratio5.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.67%
Min EPS beat(2)0.62%
Max EPS beat(2)8.73%
EPS beat(4)4
Avg EPS beat(4)4.36%
Min EPS beat(4)0.62%
Max EPS beat(4)8.73%
EPS beat(8)7
Avg EPS beat(8)19.7%
EPS beat(12)10
Avg EPS beat(12)15.73%
EPS beat(16)14
Avg EPS beat(16)19.81%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)0.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)0.52%
Revenue beat(8)4
Avg Revenue beat(8)0.76%
Revenue beat(12)7
Avg Revenue beat(12)0.84%
Revenue beat(16)9
Avg Revenue beat(16)0.97%
PT rev (1m)2.08%
PT rev (3m)-17.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.99 | ||
| Fwd PE | 7.95 | ||
| P/S | 0.11 | ||
| P/FCF | N/A | ||
| P/OCF | 5.69 | ||
| P/B | 1.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.4 |
EPS(TTM)1.66
EY11.13%
EPS(NY)1.88
Fwd EY12.57%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.62
OCFY17.58%
SpS138.26
BVpS11.34
TBVpS-14.02
PEG (NY)0.76
PEG (5Y)2.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -5.58% | ||
| ROCE | 8.84% | ||
| ROIC | 6.98% | ||
| ROICexc | 7.09% | ||
| ROICexgc | 19.17% | ||
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 20.72% | ||
| FCFM | N/A |
ROA(3y)1.96%
ROA(5y)1.01%
ROE(3y)7.17%
ROE(5y)2.44%
ROIC(3y)8.85%
ROIC(5y)7.96%
ROICexc(3y)9.22%
ROICexc(5y)8.29%
ROICexgc(3y)18.88%
ROICexgc(5y)15.44%
ROCE(3y)11.2%
ROCE(5y)10.08%
ROICexcg growth 3Y20.85%
ROICexcg growth 5Y32.45%
ROICexc growth 3Y-4.96%
ROICexc growth 5Y14.68%
OM growth 3Y3.01%
OM growth 5Y19.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.84%
GM growth 5Y12.59%
F-Score6
Asset Turnover2.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.11 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.36 | ||
| Cap/Depr | 78.81% | ||
| Cap/Sales | 2% | ||
| Interest Coverage | 1.78 | ||
| Cash Conversion | 36.87% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.45 | ||
| Altman-Z | 2.57 |
F-Score6
WACC7.88%
ROIC/WACC0.89
Cap/Depr(3y)66.67%
Cap/Depr(5y)61.64%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.74%
EPS 3Y-14.68%
EPS 5Y3.23%
EPS Q2Q%-4.55%
EPS Next Y11.89%
EPS Next 2Y17.45%
EPS Next 3Y18.74%
EPS Next 5Y15.44%
Revenue 1Y (TTM)4.22%
Revenue growth 3Y6.81%
Revenue growth 5Y1.87%
Sales Q2Q%4.95%
Revenue Next Year3.75%
Revenue Next 2Y3.75%
Revenue Next 3Y3.73%
Revenue Next 5Y5.38%
EBIT growth 1Y91.31%
EBIT growth 3Y10.02%
EBIT growth 5Y21.7%
EBIT Next Year75.06%
EBIT Next 3Y30.88%
EBIT Next 5YN/A
FCF growth 1Y-106.91%
FCF growth 3Y23.92%
FCF growth 5Y60.58%
OCF growth 1Y-29.87%
OCF growth 3Y29.74%
OCF growth 5Y44.99%